The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
Kerr DD, Jones EW, Holbert D, Huggins K.A 3-way Latin square design was used to compare the sedative and preanesthetic effects of xylazine given intravenously (i.v.) (1.1 mg./kg.) and given intramuscularly (i.m.) (2.2 mg./kg.) and acetylpromazine maleate (0.66 mg./kg.) given i.v. in the horse. Physiologic responses were recorded and clinical observations were made. Intravenous administration of xylazine and atropine sulphate (0.011 mg./kg.) appeared to have superior sedative properties, without having adverse effects on cardiovascular and respiratory systems. Both the i.v. and the i.m. administrations of xylazine prior to induction ...
Hertzsch R.Veterinarians play an essential role in the prevention of doping in equine sports, both as attending clinicians as well as official competition veterinarians. This complex task requires comprehensive knowledge concerning the pertinent regulations. These include official laws, such as the animal protection and medicines laws as as well as rules issued by the responsible equine sports authority. Furthermore, veterinarians are required to determine adequate withdrawal times following the legitimate use of medications in sport horses. This may be performed by applying appropriate data published by...
Errecalde JO, Landoni MF.The pharmacokinetics of a slow-release theophylline formulation was investigated following intravenous and oral administration at 10 mg/kg in horses. A tricompartmental model was selected to describe the intravenous plasma profile. The elimination half-life (t1/2 beta) was 16.91 +/- 0.93 h, the apparent volume of distribution (Vd) was 1.35 +/- 0.18 L/kg and the body clearance (ClB) was 0.061 +/- 0.009 L kg-1 h. After oral administration the half-life of absorption was 1.24 +/- 0.30 h, and the calculated bioavailability was above 100%. The t1/2 beta after oral administration was 18.51 +/- 1.75 ...
Drudge JH, Lyons ET, Tolliver SC.Controlled tests of the efficacy of bot-active compounds, dichlorvos, trichlorfon, trichlorfon butonate, and carbon disulfide on the larvae of Gasterophilus intestinalis and Gasterophilus nasalis during their migratory period in the tissue of the mouth of horses and ponies were completed on experimentally induced and naturally acquired infections. Against the experimental parasitisms in pony foals, the resin-pellet formulation of dichlorvos given on the feed at the dose level of 37 mg/kg, 2 formulations of trichlorfon given by stomach tube at the dose level of 40 mg/kg, another of trichlorfon ...
Ortved KF, Goodale MB, Ober C, Maylin GA, Fortier LA.Orthobiologics such as autologous conditioned serum (ACS) are often used to treat joint disease in horses. Because ACS is generated from the horse's own blood, any medication administered at the time of preparation would likely be present in stored ACS, which could lead to an inadvertent positive drug test following intra-articular (IA) injection. The main objective of this study was to determine if ACS prepared from firocoxib positive horses could result in detectable plasma concentrations of the drug following IA injection. Firocoxib was administered to six horses at 0.1mg/kg PO twice at a 2...
